These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7090936)

  • 1. Macrophage activation for tumor cytotoxicity: reactivity of peritoneal and bone marrow macrophages.
    Ruco LP; Meltzer MS; Leonard EJ; Tomisawa S
    Adv Exp Med Biol; 1982; 141():85-97. PubMed ID: 7090936
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics of peritoneal macrophages induced by asbestos injection.
    Donaldson K; Davis JM; James K
    Environ Res; 1982 Dec; 29(2):414-24. PubMed ID: 7160356
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Mar; 120(3):1054-62. PubMed ID: 632578
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
    Boraschi D; Tagliabue A
    Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional heterogeneity among peritoneal macrophages. 1. Effector cell activity of macrophages against syngeneic and xenogeneic tumor cells.
    Weinberg DS; Fishman M; Veit BC
    Cell Immunol; 1978 Jun; 38(1):94-104. PubMed ID: 667958
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor activity of macrophages grown in tumorous ascitic fluid.
    Yamazaki M; Ikenami M; Yui S; Esumi-Kurisu M; Mizuno D
    Gan; 1983 Feb; 74(1):155-61. PubMed ID: 6840434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of macrophage-mediated cytolytic activity as a tumor suppressive mechanism during maintenance of the L5178Y-tumor dormant state in DBA/2 mice.
    Robinson MK; Wheelock EF
    J Immunol; 1981 Feb; 126(2):673-9. PubMed ID: 7451990
    [No Abstract]   [Full Text] [Related]  

  • 8. Partial characterization of anti-tumor effector macrophages in the peritoneal cavities of concomitantly immune mice and mice injected with macrophage-stimulating agents.
    Hopper KE; Harrison J; Nelson DS
    J Reticuloendothel Soc; 1979 Sep; 26(3):259-71. PubMed ID: 115998
    [No Abstract]   [Full Text] [Related]  

  • 9. Natural cytotoxic macrophages in the peritoneal cavity of mice.
    Pels E; Den Otter W
    Br J Cancer; 1979 Dec; 40(6):856-61. PubMed ID: 526427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic aspects of macrophage activation for tumor cytotoxicity.
    Boraschi D
    Adv Exp Med Biol; 1982; 141():119-28. PubMed ID: 7046393
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of inoculation with neuraminidase-treated tumor cells on macrophage cytotoxicity in vitro.
    Alley CD; Snodgrass MJ
    Cancer Res; 1978 Aug; 38(8):2332-8. PubMed ID: 667829
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological surveillance mechanism of a rat brain tumor model--study of peritoneal macrophages as tumoricidal effector cells (author's transl)].
    Inoue K
    No To Shinkei; 1980 Jun; 32(6):611-5. PubMed ID: 7459139
    [No Abstract]   [Full Text] [Related]  

  • 13. Bactericidal and tumoricidal activity of lymphokine-stimulated bone marrow macrophages.
    Taskov HB
    Folia Med (Plovdiv); 1980; 22(2):5-11. PubMed ID: 6777279
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody-dependent cellular cytotoxicity against tumor cells. I. Cultivated bone marrow-derived macrophages kill tumor targets.
    Lohmann-Matthes ML; Domzig W; Taskov H
    Eur J Immunol; 1979 Apr; 9(4):261-6. PubMed ID: 467489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
    J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells.
    Doe WF; Henson PM
    J Exp Med; 1978 Aug; 148(2):544-56. PubMed ID: 568163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of natural killer cell cytotoxicity from bone marrow cells cocultivated with immune peritoneal macrophages.
    Chapes SK; Fan SS; Cummins JM; Tompkins WA
    J Reticuloendothel Soc; 1981 May; 29(5):341-55. PubMed ID: 6165823
    [No Abstract]   [Full Text] [Related]  

  • 18. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of a cytophilic factor from challenged immune peritoneal lymphocytes in specific macrophage cytotoxicity.
    Pels E; den Otter W
    Cancer Res; 1974 Nov; 34(11):3089-94. PubMed ID: 4423930
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro reactivity of macrophages and lymphocytes from ultraviolet-irradiated mice.
    Norbury KC; Kripke ML; Budmen MB
    J Natl Cancer Inst; 1977 Oct; 59(4):1231-5. PubMed ID: 903998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.